MedPath

VANOXIDE

SUMMERS LABS (as PLD) - VANOXIDE (11086-032)

Approved
Approval ID

1f0edbd9-103e-4a49-b7a8-6552ef172c13

Product Type

HUMAN PRESCRIPTION DRUG LABEL

Effective Date

Oct 9, 2023

Manufacturers
FDA

Summers Laboratories Inc

DUNS: 002382612

Products 1

Detailed information about drug products covered under this FDA approval, including NDC codes, dosage forms, ingredients, and administration routes.

BENZOYL PEROXIDE, HYDROCORTISONE

Product Details

FDA regulatory identification and product classification information

FDA Identifiers
NDC Product Code11086-032
Product Classification
G
Generic Name
BENZOYL PEROXIDE, HYDROCORTISONE
Product Specifications
Route of AdministrationTOPICAL
Effective DateOctober 9, 2023
FDA Product Classification

INGREDIENTS (2)

BENZOYL PEROXIDEActive
Quantity: 5 g in 100 g
Code: W9WZN9A0GM
Classification: ACTIB
HYDROCORTISONEActive
Quantity: 0.5 g in 100 g
Code: WI4X0X7BPJ
Classification: ACTIB

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

VANOXIDE - FDA Drug Approval Details